The effect of guanosine 5'-[fi-thio]diphosphate (GDP[fiS]), reported to be an antagonist of GTP at the Gprotein-binding site, on human platelet activation was examined. GDP [IfS] (0.3-3 mM) had significant inhibitory effects on platelet aggregation and 5-hydroxytryptamine (5HT) secretion induced by thrombin, collagen, the thromboxane mimetic U46619 and 1,2-dioctanoylglycerol (diC8) in intact platelets, as well as in saponin-permeabilized platelets. Similar inhibitory effets in intact platelets were also observed with ATP (over similar concentration ranges) and GDP and GTP (at 2-and 10-fold higher concentrations respectively). All four nucleotides also inhibited ADP-induced platelet aggregation in indomethacin-treated platelets under conditions where no 5HT secretion occurred. Inhibition of thrombin-induced aggregation and secretion by GDP [IfS] and ATP in intact platelets was accompanied by a reduction in the thrombininduced rise in intracellular Ca2" levels and 45 kDa-protein phosphorylation. The results suggest that at least some of the effects of GDP[f8S] may be unrelated to inhibition of G-protein-GTP interaction, but, instead, may be mediated via an extracellular site, common to all the nucleotides tested and perhaps via inhibition of the effects of endogenous/released ADP. The usefulness of GDP[/?S] as a tool in studying G-protein-GTP interactions in platelets is thus questionable.
INTRODUCTION
Considerable evidence implicating GTP-binding proteins (G-proteins) as effectors of agonist-induced activation processes in blood platelets is now available. This has arisen principally from two sets of observations: (i) the stimulation of diacylglycerol formation and granule secretion by GTP and stable GTP analogues, and their inhibition by the GDP analogue GDP [pS] , which prevents G-protein-GTP interaction in permeabilized platelets [1] [2] [3] [4] [5] , and (ii) the inhibition of thrombin-and U46619-induced phosphoinositide breakdown and secretion by GDP[/?S] in permeabilized platelets [6, 7] . These findings have served to substantiate the generally accepted hypothesis on the role of a specific G-protein(s) (Gp or Np) in the coupling of membrane receptors to the phosphoinositide phosphodiesterase [8, 9] and in the regulation of phosphoinositide hydrolysis. In addition to the stimulation of platelet secretion, recent work [10] has implicated G-protein-dependent phosphoinositide hydrolysis in the exposure of fibrinogen receptors, achieved via the actions of the second messengers diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (InsP3) [11, 12] .
The aim of the present study was to examine the role of G-protein-GTP interaction in collagen-induced platelet-activation processes using GDP[/?S], prompted by our recent observations on the different mechanisms involved in collagen-versus thrombin-induced arachidonate release [13] , as well as the greater importance of arachidonate metabolites in the induction of collageninduced secretion compared with secretion induced by thrombin [14] . Our results have demonstrated an inhibition of agonist (thrombin, collagen, U46619)-induced platelet aggregation and HT secretion by GDP[/IS] in intact, as well as in saponin-permeabilized, platelets, over the concentration range used by earlier workers [6, 7] . Similar inhibitory effects were also observed with GDP, GTP and ATP in intact platelets, suggesting a common extracellular site of action for these nucleotides, as these compounds are membrane-impermeable, and a need for re-interpretation of some of the earlier data obtained with GDP The increase in 32p labelling in the 45 kDa protein, the major substrate of protein kinase C [12] , was quantified by autoradiography of the dried gels, and counting the radioactivity in appropriate areas cut out from the gels.
Measurement of [Ca211i
Fluorescence measurements on quin 2-loaded washed platelets, which were incubated at 37°C and not stirred, were carried out by using a Perkin-Elmer LS5 luminescence spectrometer, with excitation at 339 nm and emission at 500 nm. Calibration of the signal and calculation of the [Ca2+]1 in nm were carried out as described previously [15] . The intracellular concentration of quin 2 ranged between 0.5 and 1 mm.
RESULTS

Saponin concentrations
Two methods were used to determine the appropriate saponin concentrations to use: (i) the extent of ATP released 30-60 s after saponin addition was measured by using the luciferase-luciferin reagent in a Lumi Aggregometer (Payton) [16] Effect of GDPIPSI on thrombin-and collagen-induced aggregation and I1'CI5HT secretion in permeabilized platelets
Initial experiments on saponization of platelets were carried out with platelets resuspended in buffer containing 3.3 mM-ATP, as used by Brass et al. [6, 7] . However, as these platelets failed to respond to thrombin (0.2 unit/ml), collagen (20 ,ug/ml) or U46619 (1 /6M), and did so only when ATP was omitted from the resuspension medium, the use of ATP in the medium was discontinued (see below for details on the effects of ATP). Aggregation and secretory responses to maximally effective concentrations of thrombin (0.2 unit/ml) and collagen (20 ,ug/ ml) were unchanged in platelets pre-treated with saponin for 1 min (Fig. la) compared with that in untreated, intact, platelets (Fig. 2 ). Significant inhibition (50-60 %) of both responses induced by both the agonists in saponin-treated platelets was observed by pre-treatment of the platelets with GDP[/?S] (1.5 or 3 mM) before saponin addition (Fig. la) .
Effect of GDPIPSI on agonist-induced aggregation and I14C15HT secretion in intact platelets: comparison with the effects of GDP, GTP and ATP The possibility that GDP[/JS] might have a direct inhibitory effect on platelet aggregation, unrelated to any effect on G-protein-GTP interaction was considered by examining the effect of this compound on agonistinduced aggregation and secretion in intact platelets, in the absence ofsaponin. Fig. 2 [18, 19] . GTP (1.5-6mM) also had an inhibitory effect, although this was weaker than that of the other nucleotides. The inhibitory effect of GTP was more pronounced at lower agonist concentrations, and Fig. 1(b) (Fig. 3) . Effect of GDPI8SI and ATP on thrombin-induced 45 kDa-protein phosphorylation
In intact 32P-labelled platelets, thrombin (0.2 unit/ml) induced a 2-3-fold increase in 32P labelling of the 45 kDa protein kinase C substrate, indicating phosphorylation of this protein (Fig. 4) . (Fig. 4) . The inhibitory effect of these compounds was much less marked against thrombin (at 1 unit/ml) (Fig. 4) . Partial inhibition (20-30 %) of diC8-induced 45 kDa-protein phosphorylation by GDP[/JS] and ATP was also observed (Fig. 4) .
DISCUSSION
Recent work demonstrating stimulation of phosphoinositide hydrolysis and platelet secretion by GTP and its stable analogues [1] [2] [3] [4] [5] , and its inhibition by GDP[/JS] [1] [2] [3] [4] [5] [6] [7] , has served to establish firmly a key role for GTPbinding proteins in stimulus-response coupling in platelets. In the present study, we sought to examine the role of these proteins in collagen-induced platelet activation using GDP[/JS] and saponin-permeabilized platelets. Our results demonstrate that, far from being a useful tool in the elucidation of the role of G-proteins, GDP[pS] can inhibit all the stages of platelet activation in intact platelets and independently of any effect on G-protein-GTP interaction. The evidence for the latter comes mainly from two of our findings: (i) inhibition of agonist-induced platelet activation in intact platelets in the absence of permeabilization makes it unlikely that inhibition is at the site of the G-protein, as these proteins are believed to be located at the intracellular surface of the plasma membrane, or even in the cytoplasm [20, 21] ;
(ii) inhibitory effects of GDP[/JS] in intact platelets are mimicked by other nucleotides, such as ATP, GDP and, most notably, GTP itself, which is suggestive ofinhibitory effects directed at ADP, a phenomenon reported several years ago in rabbit platelets by Packham et al. [22] . These workers showed that nucleoside di-and tri-phosphates such as GDP, CDP and UDP, and ATP, GTP, CTP and UTP, inhibit the conversion of ADP into ATP by the platelet enzyme nucleoside diphosphokinase and proposed that this reaction could be central to the proaggregatory effects of ADP on platelets. Moreover, Shattil & Brass [10] have suggested that inhibitory effects of GDP[/?S] at the fibrinogen receptor are mediated via inhibition of phosphoinositide hydrolysis and DAG/ InsP3 formation at the Gp or Np site; our results, which demonstrate inhibition of ADP-induced aggregation in indomethacin-treated platelets, however, suggest otherwise, and imply a direct inhibitory effect on ADPinduced aggregation/fibrinogen binding, as ADP induces very little or no phosphoinositide hydrolysis in indomethacin-treated platelets [18, 19] . The possibility that the platelets in our preparation were not intact and allowed permeation of the nucleotides can be discounted, as the stable GTP analogue, GTP[yS], which is known to induce secretion [1] [2] [3] , only did so when the platelets werre permeabilized. Thus our data strongly suggest a need for re-interpretation of earlier data from Brass et al. [6, 7, 10] , particularly on U46619 [7] and fibrinogen binding [10] , and the recent data of Authi et al. [23] that we observe in intact platelets would make it impossible to detect any additional effects on G-protein-GTP interactions and phosphoinositide hydrolysis in saponized platelets. It is most likely that inhibition of collagen-and U46619-induced secretion by GDP[/S] and the other nucleotides examined is mediated via inhibition of aggregation and/or inhibition of the effects of endogenous/released ADP. This would agree with earlier views [14, 24, 25] on the role of aggregation as well as ADP in these processes. The partial inhibition of diC8's effects (aggregation, 45 kDa-protein phosphorylation and secretion) by GDP[/JS] and ATP would also agree with the findings by Ashby et al. [26] , who demonstrated a clear role for ADP in mediating the effects of 1-oleoyl-2-acetylglycerol. However, it would be surprising if the inhibitory effects of these nucleotides are mediated entirely via inhibition of the effects of ADP, as previous work [14, 24] demonstrated a role for ADP only at low thrombin concentrations, whereas, in our study, GDP[/?S] and ATP were able to abolish all the effects of thrombin (0.2 unit/ml), which was a maximally effective concentration for inducing 5HT secretion. In this context it is unlikely that chelation of extracellular bivalent cations, such as Mg2" or Ca2", would be the cause of the inhibitory effects of the nucleotides tested, as the extent to which the extracellular Mg2" and Ca2" concentrations would be reduced by 3 mM-ATP in our resuspension medium would still be high enough to support aggregation as well as secretion induced by all the agonists tested, particularly thrombin. Moreover, although addition of EDTA or EGTA did not affect thrombin (0.2 unit/ml)-induced secretion, ATP and GDP[/?S] had strong inhibitory effects on secretion in the presence of EDTA or EGTA.
It should be mentioned that an entirely surprising finding to us is that U46619 (0.01-3 f4M), in the study by Brass et al. [7] , was able to induce any 5HT secretion at all with 3.3 mM-ATP present in the resuspension medium, as the duration of saponization in the secretion studies was similar to that in our study, and U46619, in our study, was the most sensitive of all the agonists examined to inhibition by ATP and other nucleotides, in intact as well as in saponized platelets. In other studies with permeabilized platelets, where a different permeabilization period was used, (e.g. other assays in [6] ) and in electropermeabilization studies [1] [2] [3] [4] , the inhibitory effects of ATP may not be so pronounced.
In conclusion, our results suggest that, even though GDP[f8S] may exert inhibitory effects mediated via Gprotein-GTP interaction inhibition in permeabilized platelets, these results should be interpreted with great caution, as this compound, as well as other related nucleotides, can exert inhibitory effects on agonistinduced platelet functions mediated via an extracellular site of action. This point, which makes GDP[/?S] not such a useful tool in studying G-protein-GTP interactions, at least in human platelets, as well as the role of endogenous/released ADP in platelet activation induced by other agonists, are issues of great importance which have to be resolved.
